Ziad Makhzoumi

Ziad began his career in 1981 with Booz Allen Hamilton. From 2001 to 2008, he played a pivotal role in strategic consultancy, private equity buyouts, and corporate restructuring across Europe, the Middle East, and North America.

In 2008, Ziad was appointed Chief Financial Officer (CFO) of Arabtec Holding PJSC, one of the region’s largest construction companies. During his tenure, he successfully navigated the company through one of the most challenging economic crises, maintaining financial stability in a volatile market. Under his leadership, Arabtec’s stock became the most actively traded share on the Dubai Financial Market (DFM) in both volume and value.

In 2013, Ziad transitioned to the healthcare sector as the CEO of Fakih IVF Group, where he spearheaded the transformation of a single clinic into the UAE’s market leader in fertility treatment. In 2015, he successfully negotiated the $500M sale of Fakih IVF Group to NMC Health, a publicly listed UK company, marking one of the region’s most significant healthcare transactions.

Throughout his career, Ziad has been widely recognized for his leadership, financial expertise, and impact on the business landscape. He was named Revolutionary CFO of the Year in 2009, received the Excellence in Finance Award in 2010, and was recognized as the Most Admired CFO in the Middle East in 2011.

The Wall Street Journal listed him among the Top 20 Influential Non-Royal Decision Makers in the UAE in 2010, while Arabian Business named him among the Top 500 Most Influential Arabs in the World in 2012 and one of the Top 50 Influential Brits in the UAE in 2013 and 2014. In 2014, CEO Middle East Magazine awarded him Middle East CEO of the Year in Healthcare, solidifying his reputation as a transformational leader.